ST Pharm Co.Ltd (237690) — Cash Flow Reinvestment Rate
ST Pharm Co.Ltd (237690) has a Cash Flow Reinvestment Rate of 0.90x as of September 2025, reinvesting ₩26.39 Billion (capex ₩14.61 Billion plus investments ₩-11.79 Billion) from operating cash flow of ₩29.25 Billion. See ST Pharm Co.Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ST Pharm Co.Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for ST Pharm Co.Ltd across 9 annual periods. For the full cash flow conversion analysis, see ST Pharm Co.Ltd (237690) cash flow conversion.
Annual Cash Flow Reinvestment Rate for ST Pharm Co.Ltd (2015–2025)
Year-by-year capital reinvestment analysis for ST Pharm Co.Ltd. See ST Pharm Co.Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.60x | ₩64.37 Billion | ₩13.99 Billion | ₩47.29 Billion | ▲ +196.7% |
| 2024 | 1.55x | ₩169.77 Billion | ₩109.45 Billion | ₩83.22 Billion | ▼ -98.4% |
| 2023 | 96.91x | ₩125.83 Billion | ₩1.30 Billion | ₩43.44 Billion | ▲ +926.4% |
| 2022 | 9.44x | ₩66.39 Billion | ₩7.03 Billion | ₩60.66 Billion | ▼ -27.2% |
| 2021 | 12.97x | ₩94.28 Billion | ₩7.27 Billion | ₩51.79 Billion | ▲ +400.0% |
| 2018 | 2.59x | ₩27.93 Billion | ₩10.77 Billion | ₩27.17 Billion | ▲ +408.8% |
| 2017 | 0.51x | ₩27.75 Billion | ₩54.44 Billion | ₩27.70 Billion | ▼ -62.0% |
| 2016 | 1.34x | ₩68.08 Billion | ₩50.78 Billion | ₩16.03 Billion | ▲ +24.8% |
| 2015 | 1.07x | ₩38.47 Billion | ₩35.82 Billion | ₩22.40 Billion | — |